Suchergebnisse - "Mori-Anai, Kazumi"

PubPharm (20)

1

Renal outcomes with sodium-glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes : Analysis of medical administrative databases

enthalten in: Diabetes, obesity & metabolism | 2024

von Iijima, H. | Gouda, M. | Hida, H. | +7

2

Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2024

von Iijima, H. | Shimizu, H. | Mori-Anai, K. | +4

ErratumIn: Diabetes Ther. 2024 Feb 29;:. - PMID 38421560

3

Publisher Correction : Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2024

von Iijima, H. | Shimizu, H. | Mori-Anai, K. | +4

ErratumFor: Diabetes Ther. 2024 Apr;15(4):763-777. - PMID 38117459

4

Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model

enthalten in: Diabetes therapy | 2024

von Iijima, H. | Shimizu, H. | Mori-Anai, K. | +4

5

Renal outcomes with sodium‐glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes : Analysis of medical administrative databases

enthalten in: Diabetes, Obesity and Metabolism | 2024

von Iijima, H. | Gouda, M. | Hida, H. | +7

6

Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model

enthalten in: Diabetes therapy | 2023

von Iijima, H. | Shimizu, H. | Mori-Anai, K. | +4

7

Evaluation of age-related changes in teneligliptin pharmacokinetics in Japanese and Caucasian subjects using a physiologically based pharmacokinetic model

enthalten in: ResearchSquare.com | 2023

von Iijima, H. | Shimizu, H. | Mori-Anai, K. | +4

8

Effect of canagliflozin on the decline of estimated glomerular filtration rate in chronic kidney disease patients with type 2 diabetes mellitus : A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase III study in Japan

enthalten in: Journal of diabetes investigation | 2022

von Wada, T. | Mori-Anai, K. | Takahashi, A. | +5

9

Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus : A Post-Marketing Surveillance in Japan

enthalten in: Advances in therapy | 2022

von Kadowaki, T. | Inagaki, N. | Watada, H. | +4

10

Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan

enthalten in: Advances in therapy | 2022

von Kadowaki, T. | Inagaki, N. | Watada, H. | +4